OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · IEX Real-Time Price · USD
10.02
-0.16 (-1.57%)
At close: Jul 19, 2024, 4:00 PM
10.03
+0.01 (0.10%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $183.06 million as of July 22, 2024. Its market cap has decreased by -22.59% in one year.
Market Cap
183.06M
Enterprise Value
204.35M
1-Year Change
-22.59%
Ranking
Category
Stock Price
$10.02
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $183.06M, an increase of 435.27%. That is a compound annual growth rate of 31.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 183.10M | -29.52% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coherus BioSciences | 188.15M |
| Inhibrx | 186.45M |
| Outlook Therapeutics | 186.31M |
| 908 Devices | 185.88M |
| Seres Therapeutics | 185.52M |
| XBiotech | 181.83M |
| Biomea Fusion | 181.16M |
| Ventyx Biosciences | 179.77M |